Achieve Life Sciences, Inc. SEC filings ACHV
Achieve Life Sciences, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Apr 15, 2009. Its latest annual report, Form ARS, was filed on Jun 8, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Oct 6, 2026 | Oct 5, 2026 |
| 3 | Initial insider ownership | Oct 6, 2026 | Oct 5, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 1, 2026 | Oct 1, 2026 |
| 4 | Insider transaction | Aug 21, 2026 | Aug 19, 2026 |
| 144 | Notice of proposed sale | Aug 19, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 17, 2026 | — |
| 8-K |
Current report
Other events
|
Aug 14, 2026 | Aug 14, 2026 |
| 424B5 | Prospectus supplement | Aug 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 13, 2026 | — |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 4 | Insider transaction | Jul 29, 2026 | Jul 27, 2026 |
| 4 | Insider transaction | Jul 29, 2026 | Jul 27, 2026 |
| 4 | Insider transaction | Jul 29, 2026 | Jul 27, 2026 |
| 4 | Insider transaction | Jul 29, 2026 | Jul 27, 2026 |
| 4 | Insider transaction | Jul 29, 2026 | Jul 27, 2026 |
| 4 | Insider transaction | Jul 29, 2026 | Jul 27, 2026 |
| 4 | Insider transaction | Jul 29, 2026 | Jul 27, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 28, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 27, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 8, 2026 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jul 6, 2026 | Jul 2, 2026 |
| ARS | Annual report to shareholders | Jun 8, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Jun 8, 2026 | Jun 8, 2026 |
| 4 | Insider transaction | Jun 2, 2026 | May 29, 2026 |
| 4 | Insider transaction | Jun 2, 2026 | May 29, 2026 |
| 3 | Initial insider ownership | Jun 2, 2026 | May 29, 2026 |
| 3 | Initial insider ownership | Jun 2, 2026 | May 29, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 2, 2026 | May 29, 2026 |
| PRE 14A | Preliminary proxy statement | May 29, 2026 | May 29, 2026 |
| EFFECT | Filing | May 21, 2026 | — |
| CORRESP | Letter to the SEC | May 19, 2026 | — |
| UPLOAD | Letter from the SEC | May 18, 2026 | — |
| 4 | Insider transaction | May 13, 2026 | May 11, 2026 |
| 3 | Initial insider ownership | May 13, 2026 | May 11, 2026 |
| S-8 | Employee stock plan registration | May 12, 2026 | — |
| S-3 | Shelf registration | May 12, 2026 | — |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Officer or director change
|
May 12, 2026 | May 7, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 7, 2026 | — |
| 10-K/A | Amended annual report | Apr 30, 2026 | Dec 31, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | Apr 27, 2026 | — |
| 3 | Initial insider ownership | Apr 27, 2026 | Apr 17, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 24, 2026 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Apr 24, 2026 | — |
| 3 | Initial insider ownership | Apr 24, 2026 | Apr 17, 2026 |
| 3 | Initial insider ownership | Apr 24, 2026 | Apr 17, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 24, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 24, 2026 | — |
| 4 | Insider transaction | Apr 21, 2026 | Apr 18, 2026 |
| 3 | Initial insider ownership | Apr 21, 2026 | Apr 18, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Regulation FD disclosure
|
Apr 16, 2026 | Apr 15, 2026 |
| S-8 | Employee stock plan registration | Apr 16, 2026 | — |
| S-8 | Employee stock plan registration | Mar 24, 2026 | — |
| 10-K | Annual report | Mar 24, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 24, 2026 | Mar 24, 2026 |
| 4 | Insider transaction | Jan 30, 2026 | Jan 28, 2025 |
| 4 | Insider transaction | Jan 30, 2026 | Jan 28, 2025 |
| 4 | Insider transaction | Jan 30, 2026 | Jan 28, 2025 |
| 4 | Insider transaction | Jan 30, 2026 | Jan 28, 2025 |
| 4 | Insider transaction | Jan 30, 2026 | Jan 28, 2025 |
| 4 | Insider transaction | Jan 30, 2026 | Jan 28, 2025 |
| EFFECT | Filing | Jan 29, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 29, 2026 | — |
| CORRESP | Letter to the SEC | Jan 27, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 27, 2026 | — |
| S-3 | Shelf registration | Jan 23, 2026 | — |
| 3 | Initial insider ownership | Jan 12, 2026 | Jan 1, 2026 |
| 4 | Insider transaction | Dec 8, 2025 | Dec 4, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 3 | Initial insider ownership | Oct 21, 2025 | Oct 20, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 7, 2025 | Oct 6, 2025 |
| 4 | Insider transaction | Oct 3, 2025 | Oct 1, 2025 |
| 4 | Insider transaction | Sep 22, 2025 | Sep 18, 2025 |
| 4 | Insider transaction | Sep 22, 2025 | Sep 18, 2025 |
| 3 | Initial insider ownership | Sep 19, 2025 | Sep 8, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 11, 2025 | Sep 5, 2025 |
| 4 | Insider transaction | Sep 8, 2025 | Sep 4, 2025 |
| 4 | Insider transaction | Sep 8, 2025 | Sep 4, 2025 |
| 4 | Insider transaction | Sep 8, 2025 | Sep 4, 2025 |
| 4 | Insider transaction | Sep 8, 2025 | Sep 4, 2025 |
| 4 | Insider transaction | Sep 8, 2025 | Sep 4, 2025 |
| 4 | Insider transaction | Sep 8, 2025 | Sep 4, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2025 | — |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 5, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 16, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jun 27, 2025 | Jun 26, 2025 |
| 424B5 | Prospectus supplement | Jun 27, 2025 | — |
| 424B5 | Prospectus supplement | Jun 26, 2025 | — |
| 4 | Insider transaction | Jun 10, 2025 | Jun 6, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 6, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 6, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 6, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 6, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 6, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2025 | Jun 4, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 9, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 30, 2025 | — |
| ARS | Annual report to shareholders | Apr 28, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 28, 2025 | Apr 28, 2025 |
| 4 | Insider transaction | Mar 19, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Mar 19, 2025 | Mar 17, 2025 |
| 10-K | Annual report | Mar 11, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2025 | Mar 11, 2025 |
| 8-K |
Current report
Other events
|
Feb 10, 2025 | Feb 10, 2025 |
| 4 | Insider transaction | Jan 30, 2025 | Jan 28, 2025 |
| 4 | Insider transaction | Jan 30, 2025 | Jan 28, 2025 |
| 4 | Insider transaction | Jan 30, 2025 | Jan 28, 2025 |
| 4 | Insider transaction | Jan 14, 2025 | Jan 13, 2025 |
| 4 | Insider transaction | Jan 14, 2025 | Jan 13, 2025 |
| 4 | Insider transaction | Jan 14, 2025 | Jan 13, 2025 |
| 4 | Insider transaction | Jan 14, 2025 | Jan 13, 2025 |
| 4 | Insider transaction | Jan 14, 2025 | Jan 13, 2025 |
| 3 | Initial insider ownership | Jan 14, 2025 | Jan 6, 2025 |
| 3 | Initial insider ownership | Jan 14, 2025 | Jan 6, 2025 |
| S-8 | Employee stock plan registration | Jan 10, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Jan 10, 2025 | Jan 6, 2025 |
| 4 | Insider transaction | Dec 9, 2024 | Dec 6, 2024 |
| 4 | Insider transaction | Dec 9, 2024 | Dec 6, 2024 |
| 3 | Initial insider ownership | Dec 9, 2024 | Dec 5, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 9, 2024 | Dec 5, 2024 |
| S-8 | Employee stock plan registration | Dec 5, 2024 | — |
| EFFECT | Filing | Nov 18, 2024 | — |
| EFFECT | Filing | Nov 14, 2024 | — |
| CORRESP | Letter to the SEC | Nov 14, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| S-3 | Shelf registration | Nov 7, 2024 | — |
| POS AM | Filing | Nov 7, 2024 | — |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 4, 2024 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 31, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Oct 25, 2024 | — |
| 3 | Initial insider ownership | Oct 25, 2024 | Oct 15, 2024 |
| 8-K |
Current report
Material agreement
|
Sep 27, 2024 | Sep 27, 2024 |
| 424B5 | Prospectus supplement | Sep 27, 2024 | — |
| 8-K |
Current report
Officer or director change, Other events
|
Aug 26, 2024 | Aug 20, 2024 |
| 4 | Insider transaction | Aug 20, 2024 | Aug 16, 2024 |
| 4 | Insider transaction | Aug 20, 2024 | Aug 16, 2024 |
| 4 | Insider transaction | Aug 20, 2024 | Aug 16, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jul 29, 2024 | Jul 25, 2024 |
| EFFECT | Filing | Jul 8, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 3, 2024 | — |
| CORRESP | Letter to the SEC | Jul 3, 2024 | — |
| S-3 | Shelf registration | Jun 28, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 27, 2024 | Jun 27, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2024 | Jun 5, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | May 20, 2024 | — |
| SC 13G | Ownership over 5% (passive) | May 17, 2024 | — |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| EFFECT | Filing | May 6, 2024 | — |
| CORRESP | Letter to the SEC | May 2, 2024 | — |
| UPLOAD | Letter from the SEC | May 2, 2024 | — |
| S-3 | Shelf registration | Apr 26, 2024 | — |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Apr 23, 2024 | Apr 19, 2024 |
| 4 | Insider transaction | Apr 23, 2024 | Apr 19, 2024 |
| 4 | Insider transaction | Apr 23, 2024 | Apr 19, 2024 |
| 4 | Insider transaction | Apr 23, 2024 | Apr 19, 2024 |
| S-8 | Employee stock plan registration | Mar 28, 2024 | — |
| 10-K | Annual report | Mar 28, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2024 | Mar 28, 2024 |
| SC 13G | Ownership over 5% (passive) | Mar 11, 2024 | — |
| 4 | Insider transaction | Mar 6, 2024 | Mar 4, 2024 |
| 4 | Insider transaction | Mar 6, 2024 | Mar 4, 2024 |
| 8-K |
Current report
Material agreement, Agreement ended, Results of operations, Unregistered share sale, Regulation FD disclosure
|
Feb 29, 2024 | Feb 28, 2024 |
| 424B5 | Prospectus supplement | Feb 29, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 27, 2024 | — |
| 4 | Insider transaction | Jan 29, 2024 | Jan 22, 2024 |
| 4 | Insider transaction | Jan 24, 2024 | Jan 22, 2024 |
| 4 | Insider transaction | Jan 24, 2024 | Jan 22, 2024 |
| 4 | Insider transaction | Jan 24, 2024 | Jan 22, 2024 |
| 4 | Insider transaction | Jan 24, 2024 | Jan 22, 2024 |
| 4 | Insider transaction | Jan 24, 2024 | Jan 22, 2024 |
| 4 | Insider transaction | Jan 24, 2024 | Jan 22, 2024 |
| 4 | Insider transaction | Jan 24, 2024 | Jan 22, 2024 |
| 4 | Insider transaction | Jan 24, 2024 | Jan 22, 2024 |
| 8-K |
Current report
Other events
|
Dec 11, 2023 | Dec 11, 2023 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2023 | Aug 14, 2023 |
| EFFECT | Filing | Jun 23, 2023 | — |
| CORRESP | Letter to the SEC | Jun 21, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 20, 2023 | — |
| S-3 | Shelf registration | Jun 14, 2023 | — |
| 4 | Insider transaction | Jun 9, 2023 | Jun 7, 2023 |
| 4 | Insider transaction | Jun 9, 2023 | Jun 7, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Listed as
- ACHV (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Seattle, WA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 949858
- Former names
- ONCOGENEX PHARMACEUTICALS, INC. (until Jul 31, 2017); SONUS PHARMACEUTICALS INC (until Aug 7, 2008)
Other In Vitro & In Vivo Diagnostic Substances companies
- Idexx Laboratories Inc /DE IDXX
- Lantheus Holdings, Inc. LNTH
- Neogen Corp NEOG
- Celldex Therapeutics, Inc. CLDX
- Intellia Therapeutics, Inc. NTLA
- QuidelOrtho Corp QDEL
- Myriad Genetics Inc MYGN
- Alpha Teknova, Inc. TKNO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.